Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue 11, 2008, Pages 1115-1119

  León, Guillermo ^a   Segura, Álvaro ^a   Herrera, María ^a   Otero, Rafael ^b   de Siqueira França, Francisco Oscar ^c   Barbaro, Katia Cristina ^c   Cardoso, João Luiz Costa ^c   Wen, Fan Hui ^c   de Medeiros, Carlos Roberto ^c   Prado, José Carlos Lopes ^c   Malaque, Ceila María Sant'Ana ^c   Lomonte, Bruno ^a   Gutiérrez, José María ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c INSTITUTO BUTANTAN   (Brazil)

Author keywords

Adverse reactions; Anaphylactic reaction; Antivenoms; F(ab )2; Heterophilic antibodies; IgG; Snake bite

Indexed keywords

HETEROPHILE ANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; SNAKE VENOM; SNAKE VENOM ANTISERUM;

ADULT; ANAPHYLAXIS; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BRAZIL; COLOMBIA; CONTROLLED STUDY; ENVENOMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; MAJOR CLINICAL STUDY; SNAKEBITE; VOLUNTEER;

ANAPHYLAXIS; ANIMALS; ANTIBODIES, HETEROPHILE; ANTIVENINS; BRAZIL; COLOMBIA; COSTA RICA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HORSES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; SNAKE BITES; SNAKE VENOMS; STATISTICS AS TOPIC;

EQUIDAE;

EID: 53549122233     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.04.038     Document Type: Article

References (27)

1. Ayuso R., Lehrer S.B., López M., Reese G., Ibáñez M.D., Martín Esteban M., Ownby D.R., and Schwartz H. Identification of bovine IgG as a major cross-reactive vertebrate meat allergen. Allergy 55 (2000) 348-354
2. Barandun S., Kistler P., Jeunet F., and Isliker H. Intravenous administration of human γ-globulin. Vox Sang. 7 (1962) 157-174
3. Burnouf T., Griffiths E., Padilla A., Seddik S., Stephano M.A., and Gutiérrez J.M. Assessment of the viral safety of antivenoms fractionated from equine plasma. Biologicals 32 (2004) 115-128
4. 2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators. Trans. R. Soc. Trop. Med. Hyg. 92 (1998) 657-662
5. Gawarammana I.B., Kularatne S.A.M., Dissanayake W.P., Kumarasiri R.P.V., Senanayake N., and Ariyasena H. Parallel infusion of hydrocortisone ± chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites. Med. J. Aust. 180 (2004) 20-23
6. Good Manufacturing Practices, 1999. Medicinal products for human and veterinary use, the rules governing medicinal products in the European Union, Vol. 4. 1992 ed. Anex 1(82).
7. Henning C.H., Rink L., Fagin U., Jabs W.J., and Kirchner H. The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAs. J. Immunol. Methods 235 (2000) 71-80
8. Herrera M., León G., Segura A., Meneses F., Lomonte B., Chippaux J.P., and Gutiérrez J.M. Factors associated with adverse reactions induced by whole IgG preparations: comparison between horse, sheep and camel IgGs. Toxicon 46 (2005) 775-781
9. Houssien D.A., Jónsson T., Davies E., and Scott D.L. Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis. Scand. J. Rheumatol. 27 (1998) 46-53
10. Jancar S., and Sánchez M. Immune complex-mediated tissue injury: a multistep paradigm. Trends Immunol. 26 (2005) 48-55
11. Jones R.G.A., and Landon J. A protocol for 'enhanced pepsin digestion': a step by step method for obtaining pure antibody fragments in high yield from serum. J. Immunol. Methods 275 (2003) 239-250
12. 2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon 35 (1997) 1627-1637
13. León G., Lomonte B., and Gutiérrez J.M. Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols. Toxicon 45 (2005) 123-128
14. LoVecchio F., Klemens J., Roundy E.B., and Klemens A. Serum sickness following administration of Antivenin (Crotalidae) Polyvalent in 181 cases of presumed rattlesnake envenomation. Wilderness Environ. Med. 14 (2003) 220-221
15. Malasit P., Warrell D.A., Chanthavanich P., Viravan C., Mongkolsapaya J., Singhthong B., and Supich C. Prediction, prevention and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites. Br. Med. J. (Clin. Res. Ed.) 292 (1986) 17-20
16. 2 fragments. Toxicon 32 (1994) 725-734
17. Moran N.F., Newman W.J., Theakston R.D.G., Warrell D.A., and Wilkinson D. High incidence of early anaphylactoid reaction to SAIMR polyvalent snake antivenom. Trans. R. Soc. Trop. Med. Hyg. 92 (1998) 69-70
18. Nielsen H., Sorensen H., Faber V., and Svehag S.E. Circulating immune complexes, complement activation kinetics and serum sickness following treatment with heterologous anti-snake venom globulin. Scand. J. Immunol. 7 (1978) 25-33
19. Otero R., León G., Gutiérrez J.M., Rojas G., Toro M.F., Barona J., Rodríguez V., Díaz A., Nuñez V., Quintana J.C., Ayala S., Mosquera D., Conrado L.L., Fernández D., Arroyo Y., Paniagua C.A., López M., Ospina C.E., Alzate C., Fernández J., Meza J.J., Silva J.F., Ramírez P., Fabra P.E., Ramírez E., Córdoba E., Arrieta A.B., Warrell D.A., and Theakston R.D.G. Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without β-propiolactone, in the treatment of Bothrops asper bites in Colombia. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 1173-1182
20. Pope R.M., and McDuffy S.J. IgG rheumatoid factor: analysis of various species of IgG for detection by radioimmunoassay. J. Lab. Clin. Med. 6 (1981) 842-853
21. Rojas G., Jiménez J.M., and Gutiérrez J.M. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production. Toxicon 32 (1994) 351-363
22. Sandler S.G., Mallory D., Malamut D., and Eckrich R. IgA anaphylactic transfusion reactions. Transfus. Med. Rev. 9 (1995) 1-8
23. Sevcik C., Díaz P., and D'Suze G. On the presence of antibodies against bovine, equine and poultry immunoglobulins in human IgG preparations, and its implications on antivenom production. Toxicon 51 (2008) 10-16
24. Sutherland S.K. Serum reactions. An analysis of commercial antivenoms and the possible role of anticomplementary activity in de-novo reactions to antivenoms and antitoxins. Med. J. Aust. 1 (1977) 613-615
25. Theakston R.D., Warrell D.A., and Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 41 (2003) 541-557
26. Warrell D.A. Clinical toxicology of snakebite in Asia. In: Meier J., and White J. (Eds). Handbook of Clinical Toxicology of Animal Venoms and Poisons (1995), CRC Press, Boca Raton, FL 493-594
27. Williams D.J., Jensen S.D., Nimorakiotakis B., Müller R., and Winkel K.D. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea. Toxicon 49 (2007) 780-792